BRIMONIDINE TARTRATE
| Brand name | LUMIFY |
|---|---|
| Active ingredient | BRIMONIDINE TARTRATE |
| Strength | 0.025% |
| Dosage form | SOLUTION/DROPS |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | December 2017 |
| Marketing status | OTC |
| Patent | Expires | Type |
|---|---|---|
| 8293742 | July 2030 | use U-2222 |
| 9259425 | July 2030 | use U-2222 |
| 11596600 | July 2029 | use U-2222 |
| 11833245 | July 2029 | use U-2222 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.